Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Spy1 interacts with p27Kip1 to allow G1/S progression.
Porter LA
,
Kong-Beltran M
,
Donoghue DJ
.
???displayArticle.abstract???
Progression through the G1/S transition commits cells to synthesize DNA. Cyclin dependent kinase 2 (CDK2) is the major kinase that allows progression through G1/S phase and subsequent replication events. p27 is a CDK inhibitor (CKI) that binds to CDK2 to prevent premature activation of this kinase. Speedy (Spy1), a novel cell cycle regulatory protein, has been found to prematurely activate CDK2 when microinjected into Xenopus oocytes and when expressed in mammalian cells. To determine the mechanism underlying Spy1-induced proliferation in mammalian cell cycle regulation, we used human Spy1 as bait in a yeast two-hybrid screen to identify interacting proteins. One of the proteins isolated was p27; this novel interaction was confirmed both in vitro, using bacterially expressed and in vitro translated proteins, and in vivo, through the examination of endogenous and transfected proteins in mammalian cells. We demonstrate that Spy1 expression can overcome a p27-induced cell cycle arrest to allow for DNA synthesis and CDK2 histone H1 kinase activity. In addition, we utilized p27-null cells to demonstrate that the proliferative effect of Spy1 depends on the presence of endogenous p27. Our data suggest that Spy1 associates with p27 to promote cell cycle progression through the G1/S transition.
Baldassarre,
Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27.
2000, Pubmed
Baldassarre,
Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27.
2000,
Pubmed
Carrano,
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.
1999,
Pubmed
Chen,
High-efficiency transformation of mammalian cells by plasmid DNA.
1987,
Pubmed
Cheng,
The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.
1999,
Pubmed
Durand,
Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation.
1997,
Pubmed
,
Xenbase
Jeffrey,
Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.
1995,
Pubmed
Karaiskou,
Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins.
2001,
Pubmed
,
Xenbase
Koff,
Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.
1993,
Pubmed
Kong,
Cyclin F regulates the nuclear localization of cyclin B1 through a cyclin-cyclin interaction.
2000,
Pubmed
,
Xenbase
Lenormand,
Speedy: a novel cell cycle regulator of the G2/M transition.
1999,
Pubmed
,
Xenbase
Montagnoli,
Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation.
1999,
Pubmed
Morgan,
Principles of CDK regulation.
1995,
Pubmed
Morisaki,
Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
1997,
Pubmed
Nakanishi,
Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1.
1995,
Pubmed
Nakayama,
Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1.
2001,
Pubmed
Pagano,
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
1995,
Pubmed
Polyak,
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
1994,
Pubmed
Porter,
Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.
2002,
Pubmed
,
Xenbase
Reynisdóttir,
The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2.
1997,
Pubmed
Rodier,
p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis.
2001,
Pubmed
Sheaff,
Cyclin E-CDK2 is a regulator of p27Kip1.
1997,
Pubmed
Sherr,
CDK inhibitors: positive and negative regulators of G1-phase progression.
1999,
Pubmed
Sherr,
G1 phase progression: cycling on cue.
1994,
Pubmed
Slingerland,
A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells.
1994,
Pubmed
Slingerland,
Regulation of the cdk inhibitor p27 and its deregulation in cancer.
2000,
Pubmed
Sutterlüty,
p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells.
1999,
Pubmed
Tomoda,
Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.
1999,
Pubmed
Toyoshima,
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
1994,
Pubmed
Tsvetkov,
p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27.
1999,
Pubmed
Vidal,
Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status.
2002,
Pubmed
Vlach,
Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
1997,
Pubmed
Vojtek,
Mammalian Ras interacts directly with the serine/threonine kinase Raf.
1993,
Pubmed
Vojtek,
Ras-Raf interaction: two-hybrid analysis.
1995,
Pubmed
